SCHEMBL6423936

SCHEMBL6423936

CCC[C@@](C)(C(=O)O)c1c(C)n(C(=O)c2ccc(Cl)c(Cl)c2)c2ccc(O)c(F)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 2/20 0.35
AKR1C3 P42330 6/20 0.35
AKR1C2 P52895 6/20 0.35
PTGS1 P23219 2/20 0.33
PTGS2 P35354 2/20 0.33
TSHR P16473 2/20 0.32
NOTUM Q6P988 1/20 0.32
HSP90AA1 P07900 2/20 0.32
HSP90AB1 P08238 2/20 0.32
PPARG P37231 2/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 2/20 0.30
KCNH2 Q12809 1/20 0.30
CACNA1I Q9P0X4 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
PTGES O14684 1/20 0.30
ABCC3 O15438 1/20 0.30
ABCC4 O15439 1/20 0.30
MT-CO2 P00403 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6427346 0.95 TSHR (0.35) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6463238 0.94 AKR1C3 (0.34) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6425861 0.93 ABCB11 (0.36) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6424231 0.90 TSHR (0.34) AKR1C3AKR1C2PTGS1PTGS2TSHR
SCHEMBL6424444 0.90 AKR1C3 (0.42) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6424381 0.89 AKR1C3 (0.34) AKR1C3AKR1C2PTGS1PTGS2HSP90AA1
SCHEMBL6462995 0.88 AKR1C3 (0.33) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6426966 0.88 AKR1C3 (0.35) AKR1C3AKR1C2PTGS1PTGS2NOTUM
SCHEMBL6424868 0.86 ABCB11 (0.36) ABCB11AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6462020 0.86 AKR1C3 (0.35) ABCB11AKR1C3AKR1C2PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 ABCB11 4380/4885AKR1C3 577/4885AKR1C2 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.